Use this form to add your product announcement, press release, case study or white paper to our web site.
Please Note: All submitted content is subject to approval before it will appear on the live web site.
Please make sure to include your contact information at the bottom of your post in case we need to contact you in regards to your submission.
Test- What Will It Take—And What Does It Look Like—For Clinical Care and Clinical Research To Converge?Clinical Research News | A profound shift is underway: one that positions patients not merely as recipients of clinical care but as active participants and collaborators in clinical research. A panel at last week’s SCOPE Summit Europe took on this challenge.
- SCOPE Europe 2024 Announces Best of Show WinnersClinical Research News | Clinical Research News and ClinEco announced three Best of Show winners today at the 2024 SCOPE Europe conference in Barcelona, Spain. The winning companies that submitted their products include Anju Software, Greenphire, and Medidata.
- IQVIA Introduces New AI Assistant, DHL Express, Thermo Fisher Partnership, Novel Cellular Blood Pressure Monitor, MoreClinical Research News | IQVIA introduces IQVIA AI Assistant; DHL Express and Thermo Fisher Scientific join forces to drive more sustainable clinical research services; Withings Health Solutions announces a first-of-its-kind cellular blood pressure monitor; and more.
- Follow the Money: Trials for Major Depressive Disorder Therapies, Kidney Disease Treatment, MoreClinical Research News | Seaport Therapeutics plans to advance their therapeutic candidate SPT-300, an oral prodrug of allopregnanolone; Purespring Therapeutics will initiate a clinical trial for IgAN, a common, chronic kidney disease primarily affecting young adults; and more.
- Advancing Health Equity: Community-First Approach to Drive Diversity in Clinical ResearchClinical Research News | In clinical research, one ongoing challenge continues to persist: a lack of diverse representation. While the root cause stems from a combination of limited access and endemic mistrust of the health care system among certain communities, the outcome is that large pockets of communities are often excluded from studies, even in […]
- SCOPE Europe 2024 Best of Show EntriesClinical Research News | The results are in: there are twelve new product finalists in the 2024 SCOPE Europe Best of Show awards that will be on display next week in Barcelona. Starting at the opening reception, the SCOPE Europe community is invited to identify exceptional innovation in technologies used by life science professionals, voting […]
- Drug Developers Eying Rollout of AI Legislation in the EUClinical Research News | Eyes around the globe are on the EU Artificial Intelligence (AI) Act—the first comprehensive legal framework on AI anywhere—which will likely influence the direction of regulatory oversight measures adopted elsewhere, include other major markets such as the United States. Differing perspectives on the Act, including if and to what extent it […]
- Estrogen’s Impact on Cancer Reveals New Treatment OptionsClinical Research News | A groundbreaking new approach for treating triple-negative breast cancer is moving forward, thanks to discoveries from Dr. Donald McDonnell’s lab at Duke University. Traditionally, hormone therapies have only been considered effective for estrogen receptor-positive cancers, but McDonnell’s research suggests that estrogen modulation could also impact TNBC.
- Psst! Need a Simple and Reliable Eye Tracker for Your Brain Studies?Clinical Research News | A mechanical engineer at the University of Houston is seeking physician collaborators with a research need for a small but sensitive wearable eye-tracking system to provide continuous data on human brain activity. The need was suggested by a survey of the literature, which found that a shortage of data coming from […]
- Catching Up With Jill Pellegrino, Now Leading AutoCruitmentClinical Research News | For as long as most people can remember, patient enrollment into clinical trials has been abysmal—so much so that 80% of studies don’t finish on time and 55% end due to low accrual rates. The underlying issue is overreliance on study sites to find participants on their own.
By submitting this form, I authorize I have approval to submit content on behalf on my respective company.
Please email shannong@webcomcommunications.com if you have any questions.
